TARGETED RADIONUCLIDE THERAPY OF MELANOMA: ANTI-TUMOURAL EFFICACY OF A NEW IODINE-131 LABELLED AGENT

被引：0
|
作者：
Bonnet, M. [1 ]
Papon, J. [1 ]
Mishellany, F. [2 ]
Labarre, P. [1 ]
Maublant, J. [3 ]
Penault-Llorca, F. [2 ]
Cayre, A. [2 ]
Miot-Noirault, E. [1 ]
Madelmont, J. [1 ]
Chezal, J. [1 ]
Moins, N. [1 ]
机构：
[1] Univ Auvergne, CJP, EA4231, Clermont Ferrand, France
[2] Ctr Jean Perrin, Anat Pathol Lab, Clermont Ferrand, France
[3] Ctr Jean Perrin, Nucl Med Serv, Clermont Ferrand, France
来源：
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 2009年 / 52卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [41] Synthesis and biodistribution studies of iodine-131 D-amino acid YYK peptide as a potential therapeutic agent for labeling an anti-CD20 antibody
    Sadri, K.
    Gandomkar, M.
    Babaei, M. H.
    Najafi, R.
    Zakavi, S. R.
    Ebrahimi, S. E. Sadat
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 (7-8): : 289 - 294
  • [42] Predictive Value of a Thyroid-Absorbed Dose with a Shorter Effective Half-Life on Efficacy in Graves Disease Patients Receiving Iodine-131 Therapy
    Yu, Feng
    Zhang, Ruiguo
    Zhang, Guizhi
    Meng, Zhaowei
    Liu, Xiaohua
    He, Yajing
    Tan, Jian
    Wang, Renfei
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [43] Efficacy of Targeted Radionuclide Therapy Using [131I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma
    Akil, Hussein
    Quintana, Mercedes
    Raymond, Jeremy H.
    Billoux, Tommy
    Benboubker, Valentin
    Besse, Sophie
    Auzeloux, Philippe
    Delmas, Veronique
    Petit, Valerie
    Larue, Lionel
    D'Incan, Michel
    Degoul, Francoise
    Rouanet, Jacques
    CANCERS, 2021, 13 (06) : 1 - 20
  • [44] Phase I study of [131I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol
    Emilie Thivat
    Jacques Rouanet
    Philippe Auzeloux
    Nicolas Sas
    Elodie Jouberton
    Sophie Levesque
    Tommy Billoux
    Sandrine Mansard
    Ioana Molnar
    Marion Chanchou
    Giovanna Fois
    Lydia Maigne
    Jean-Michel Chezal
    Elisabeth Miot-Noirault
    Michel D’Incan
    Xavier Durando
    Florent Cachin
    BMC Cancer, 22
  • [45] 131I-Labeled Anti-HER2 Nanobody for Targeted Radionuclide Therapy of HER2-Positive Breast Cancer
    Zhao, Lingzhou
    Gong, Jiali
    Qi, Qinli
    Liu, Changcun
    Su, Hongxing
    Xing, Yan
    Zhao, Jinhua
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2023, 18 : 1915 - 1925
  • [46] COMBINATION OF ANTIGEN-SPECIFIC VACCINATION AND TARGETED RADIONUCLIDE THERAPY IMPROVES ANTI-TUMOR EFFICACY IN A MURINE PROSTATE MODEL
    Potluri, Hemanth
    Ferreira, Carolina
    Grudzinski, Joseph
    Massey, Christopher
    Hernandez, Reinier
    Weichert, Jamey
    McNeel, Douglas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A624 - A624
  • [47] Evaluation of new iodinated acridine derivatives for targeted radionuclide therapy of melanoma using 125I, an Auger electron emitter
    Gardette, Maryline
    Papon, Janine
    Bonnet, Mathilde
    Desbois, Nicolas
    Labarre, Pierre
    Wu, Ting-Dee
    Miot-Noirault, Elisabeth
    Madelmont, Jean-Claude
    Guerquin-Kern, Jean-Luc
    Chezal, Jean-Michel
    Moins, Nicole
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (06) : 1253 - 1263
  • [48] ICF15002, a New Fluorinated and Iodinated Melanin-Targeting Compound for Melanoma PET Imaging and Targeted Radionuclide Therapy
    Rbah-Vidal, L.
    Billaud, E.
    Vidal, A.
    Besse, S.
    Labarre, P.
    Askienazy, S.
    Miot-Noirault, E.
    Auzeloux, P.
    Chezal, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S324 - S324
  • [49] Abscopal effect following targeted radionuclide therapy in metastatic melanoma: preclinical studies in a new double-tumor mouse model
    Delmas, M.
    Harismendy, N.
    Chaussin, B.
    Montemagno, C.
    Durivault, J.
    Miot-Noirault, E.
    Cachin, F.
    Auzeloux, P.
    Douge, A.
    Rouzaire, P.
    Besse, S.
    Chautard, E.
    Jouberton, E.
    Michel, D.
    Rouanet, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S320 - S320
  • [50] Evaluation of new iodinated acridine derivatives for targeted radionuclide therapy of melanoma using 125I, an Auger electron emitter
    Maryline Gardette
    Janine Papon
    Mathilde Bonnet
    Nicolas Desbois
    Pierre Labarre
    Ting-Dee Wu
    Elisabeth Miot-Noirault
    Jean-Claude Madelmont
    Jean-Luc Guerquin-Kern
    Jean-Michel Chezal
    Nicole Moins
    Investigational New Drugs, 2011, 29 : 1253 - 1263
12345